The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to estimate the effect of fluconazole (200 mg BID for 2 days), a
moderate CYP3A4 inhibitor on the pharmacokinetics of a single 8 mg oral dose of fesoterodine
in healthy adult subjects.